TABLE 3.
Distribution of demographical and clinical variables according to type of RH (after propensity matching analysis)
| Variable | Total (N=738) | Nerve-sparing RH (N=369) |
Non–nerve-sparing RH (N=369) |
P value |
|---|---|---|---|---|
| Age (y) | .82 | |||
| ≤45 | 391 (53.0) | 197 (53.4) | 194 (52.6) | |
| >45 | 347 (47.0) | 172 (46.6) | 175 (47.4) | |
| Pathologic stage | .67 | |||
| IB1 | 683 (92.5) | 343 (93.0) | 340 (92.1) | |
| IIA1 | 55 (7.5) | 26 (7.0) | 29 (7.9) | |
| Grade | .21 | |||
| 1 | 70 (9.5) | 42 (11.4) | 28 (7.6) | |
| 2 | 511 (69.2) | 251 (68.0) | 260 (70.5) | |
| 3 | 157 (21.3) | 76 (20.6) | 81 (22.0) | |
| LVSI | .97 | |||
| No | 385 (52.2) | 191 (51.8) | 194 (52.6) | |
| Yes | 281 (38.1) | 142 (38.5) | 139 (37.7) | |
| Unknown | 72 (9.8) | 36 (9.8) | 36 (9.8) | |
| Histology | .91 | |||
| Squamous | 500 (67.8) | 247 (66.9) | 253 (68.6) | |
| Adenocarcinoma | 190 (25.7) | 96 (26.0) | 94 (25.5) | |
| Adenosquamous | 38 (5.1) | 21 (5.7) | 17 (4.6) | |
| Others | 10 (1.4) | 5 (1.4) | 5 (1.4) | |
| Diameter | .82 | |||
| ≤20 mm | 351 (47.6) | 174 (47.2) | 177 (48.0) | |
| 21–40 mm | 387 (52.4) | 195 (52.8) | 192 (52.0) | |
| Adjuvant therapy | .57 | |||
| No | 521 (70.6) | 257 (69.6) | 264 (71.5) | |
| Yes | 217 (29.4) | 112 (30.4) | 105 (28.5) |
LVSI, lymphovascular space invasion; RH, radical hysterectomy.